These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2011-002441-34 Ensayo clínico fase II, abierto, no controlado y multicéntrico de pazopanib en monoterapia para determinar la eficacia y la seguridad en segunda línea de tratamiento en pacientes con carcinoma de célu... bad-data
Reported results 2012-001337-13 A randomized phase II study to explore the efficacy and feasibility of upfront rotations between sunitinib and everolimus versus sequential treatment of first line sunitinib and second line everolimus... 2017-05-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002826-55 A randomised Phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium 2016-01-12 bad-data
Ongoing 2017-004260-36 Phase II multicentre, randomized, open-label study to evaluate the safety and efficacy of avelumab with gemcitabine/carboplatin versus gemcitabine/carboplatin alone in patients with unresectable or me... not-yet-due
Ongoing 2017-004486-27 Phase II Study of Paclitaxel and TAK-228 in metastatic urothelial carcinoma (UC) and the impact of PI3K-mTOR pathway genomic alterations not-yet-due